A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Idiopathic Pulmonary Fibrosis
Related studies linked through entity extraction aliases.
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
- Status
- COMPLETED
- Phase
- PHASE2
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
- Status
- RECRUITING
- Phase
- PHASE2
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- TERMINATED
- Phase
- PHASE2
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
- Status
- COMPLETED
- Phase
- PHASE1
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
- Status
- RECRUITING
- Phase
- PHASE2
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- Status
- RECRUITING
- Phase
- PHASE3
Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)
- Status
- RECRUITING
- Phase
- PHASE1
A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib
- Status
- COMPLETED
- Phase
- N/A
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
- Status
- TERMINATED
- Phase
- PHASE2
A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis Patients
- Status
- COMPLETED
- Phase
- N/A
The Effect of N115 on Coughing in IPF Patients
- Status
- COMPLETED
- Phase
- PHASE3